UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 96

Sortiert nach

Docetaxel (Taxotere ) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group

British journal of cancer, 1994-08, Vol.70 (2), p.380-383

1994

Volltextzugriff (PDF)

Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion

Journal of clinical oncology, 1993-05, Vol.11 (5), p.950-958

1993

Volltextzugriff (PDF)

Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer

European journal of cancer (1990), 1997-02, Vol.33 (2), p.214-219

1997

Volltextzugriff (PDF)

Docetaxel (TaxotereTM) in advanced gastric cancer : results of a phase II clinical trial

British journal of cancer, 1994-08, Vol.70 (2), p.380-383

1994

Volltextzugriff (PDF)

Docetaxel (Taxotere®): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck

Annals of oncology, 1994-07, Vol.5 (6), p.533-537

1994

Volltextzugriff (PDF)

Phase I and pharmacokinetic study of taxotere (RP 56976; NSC 628503) given as a short intravenous infusion

Cancer research (Chicago, Ill.), 1993-03, Vol.53 (5), p.1037-1042

1993

Volltextzugriff (PDF)

Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis

Journal of clinical oncology, 1994-07, Vol.12 (7), p.1458-1467

1994

Volltextzugriff (PDF)

Phase II study with Docetaxel (Taxotere®) in advanced soft tissue sarcomas of the adult

Annals of oncology, 1994-07, Vol.5 (6), p.539-542

1994

Volltextzugriff (PDF)

Phase I and pharmacokinetic study of taxotere (RP 56976) administered as a 24-hour infusion

Cancer research (Chicago, Ill.), 1993-02, Vol.53 (3), p.523-527

1993

Volltextzugriff (PDF)

Population pharmacokinetics of docetaxel during phase I studies using nonlinear mixed-effect modeling and nonparametric maximum-likelihood estimation

Cancer chemotherapy and pharmacology, 1995-01, Vol.37 (1-2), p.47-54

1995

Volltextzugriff (PDF)

Docetaxel (Taxotere ), a novel taxoid, in the treatment of advanced colorectal carcinoma: an EORTC Early Clinical Trials Group Study

British journal of cancer, 1994-08, Vol.70 (2), p.376-379

1994

Volltextzugriff (PDF)

Phase I study of RP 49532A, a new protein-synthesis inhibitor, in patients with advanced refractory solid tumors

Cancer chemotherapy and pharmacology, 1995-01, Vol.35 (3), p.246-248

1995

Volltextzugriff (PDF)

Taxotere is active in advanced gastric carcinoma: Results of a phase II clinical trial

European journal of cancer (1990), 1993, Vol.29, p.S101-S101

1993

Volltextzugriff (PDF)

Determination of reliability criteria for liver stiffness evaluation by transient elastography

Hepatology (Baltimore, Md.), 2013-03, Vol.57 (3), p.1182-1191

2013

Volltextzugriff (PDF)

Clinical pharmacology of high-dose etoposide associated with cisplatin. Pharmacokinetic and metabolic studies

European journal of cancer & clinical oncology, 1987-11, Vol.23 (11), p.1627-1632

1987

Volltextzugriff (PDF)

Effects of Freezing and Thawing Processes on the Quality of Atlantic Salmon (Salmo salar) Fillets

Journal of food science, 2007-06, Vol.72 (5), p.E279-E284

2007

Volltextzugriff (PDF)

Monoubiquitination and Endocytosis Direct γ-Secretase Cleavage of Activated Notch Receptor

The Journal of cell biology, 2004-07, Vol.166 (1), p.73-83

2004

Volltextzugriff (PDF)

A Novel Proteolytic Cleavage Involved in Notch Signaling: The Role of the Disintegrin-Metalloprotease TACE

Molecular cell, 2000-02, Vol.5 (2), p.207-216

2000

Volltextzugriff (PDF)

Proteomic analysis identifies argininosuccinate synthase 1 as a useful biomarker for hepatocellular adenoma classification and patient management

Journal of hepatology, 2017, Vol.66 (1), p.S228-S229

2017

Volltextzugriff (PDF)

Recurrent INHBE-GLI1 fusions in hepatocellular adenomas with sonic hedgehog pathway activation

Journal of hepatology, 2017, Vol.66 (1), p.S14-S14

2017

Volltextzugriff (PDF)

THU-121 - Proteomic analysis identifies argininosuccinate synthase 1 as a useful biomarker for hepatocellular adenoma classification and patient management

Journal of hepatology, 2017, Vol.66 (1), p.S228-S229

2017

Volltextzugriff (PDF)

N- and C-terminal sequences control degradation of MAD3/I kappa B alpha in response to inducers of NF-kappa B activity

Molecular and Cellular Biology, 1995-10, Vol.15 (10), p.5339-5345

1995

Volltextzugriff (PDF)

How I do…the diagnosis of a cervical pregnancy

Gynécologie, obstétrique, fertilité & sénologie, 2021-02, Vol.49 (2), p.137-142

2021

Volltextzugriff (PDF)

Common variable immunodeficiency disorders: Part 2. Updated clinical manifestations and therapeutic management

La revue de medecine interne, 2021-07, Vol.42 (7), p.473-481

2021

Volltextzugriff (PDF)

1 – 25 von 96

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(92)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Docetaxel (Taxotere ) in advanced gastric cancer: results of a phase II clinical trial. EORTC Early Clinical Trials Group

Phase I clinical trial of taxotere administered as either a 2-hour or 6-hour intravenous infusion

Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer

Docetaxel (TaxotereTM) in advanced gastric cancer : results of a phase II clinical trial

Docetaxel (Taxotere®): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck

Phase I and pharmacokinetic study of taxotere (RP 56976; NSC 628503) given as a short intravenous infusion

Phase I study of docetaxel administered as a 1-hour intravenous infusion on a weekly basis

Phase II study with Docetaxel (Taxotere®) in advanced soft tissue sarcomas of the adult

Phase I and pharmacokinetic study of taxotere (RP 56976) administered as a 24-hour infusion

Population pharmacokinetics of docetaxel during phase I studies using nonlinear mixed-effect modeling and nonparametric maximum-likelihood estimation

Docetaxel (Taxotere ), a novel taxoid, in the treatment of advanced colorectal carcinoma: an EORTC Early Clinical Trials Group Study

Phase I study of RP 49532A, a new protein-synthesis inhibitor, in patients with advanced refractory solid tumors

Taxotere is active in advanced gastric carcinoma: Results of a phase II clinical trial

Determination of reliability criteria for liver stiffness evaluation by transient elastography

Etomidate versus ketamine for rapid sequence intubation in acutely ill patients: a multicentre randomised controlled trial

Clinical pharmacology of high-dose etoposide associated with cisplatin. Pharmacokinetic and metabolic studies

Effects of Freezing and Thawing Processes on the Quality of Atlantic Salmon (Salmo salar) Fillets

Monoubiquitination and Endocytosis Direct γ-Secretase Cleavage of Activated Notch Receptor

A Novel Proteolytic Cleavage Involved in Notch Signaling: The Role of the Disintegrin-Metalloprotease TACE

Proteomic analysis identifies argininosuccinate synthase 1 as a useful biomarker for hepatocellular adenoma classification and patient management

Recurrent INHBE-GLI1 fusions in hepatocellular adenomas with sonic hedgehog pathway activation

THU-121 - Proteomic analysis identifies argininosuccinate synthase 1 as a useful biomarker for hepatocellular adenoma classification and patient management

N- and C-terminal sequences control degradation of MAD3/I kappa B alpha in response to inducers of NF-kappa B activity

How I do…the diagnosis of a cervical pregnancy

Common variable immunodeficiency disorders: Part 2. Updated clinical manifestations and therapeutic management

Suchergebnisse filtern